Hot Features
プレミアム
Sarepta Therapeutics Inc New (SRPT)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-03-11 | Mr. Ian Michael EstepanPresident & COO | -1.10k | 18.68k | Sale to Issuer | 17.03 | 201.98k | -0.54% |
| 2026-03-11 | Mr. Ryan H. WongExec. VP & CFO | -256.00 | 4.36k | Sale to Issuer | 17.03 | 135.06k | -0.19% |
| 2026-03-11 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -948.00 | 16.14k | Sale to Issuer | 17.03 | 225.32k | -0.42% |
| 2026-03-12 | Dr. Stephen L. MayoIndependent Director | -7.24k | 123.21k | 売り | 17.02 | 1.77k | -80.40% |
| 2026-03-11 | Cristin Rothfussインサイダー | -974.00 | 16.59k | Sale to Issuer | 17.03 | 137.54k | -0.70% |
| 2026-03-09 | Mr. Ryan H. WongExec. VP & CFO | -275.00 | 4.66k | Sale to Issuer | 16.95 | 135.32k | -0.20% |
| 2026-03-09 | Cristin Rothfussインサイダー | -830.00 | 14.07k | Sale to Issuer | 16.95 | 138.52k | -0.60% |
| 2026-03-09 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -1.40k | 23.71k | Sale to Issuer | 16.95 | 226.27k | -0.61% |
| 2026-03-09 | Mr. Ian Michael EstepanPresident & COO | -1.62k | 27.44k | Sale to Issuer | 16.95 | 203.08k | -0.79% |
| 2026-03-02 | Cristin Rothfussインサイダー | -408.00 | 6.61k | Sale to Issuer | 16.20 | 139.35k | -0.29% |
| 2026-03-02 | Mr. Ryan H. WongExec. VP & CFO | -450.00 | 7.29k | Sale to Issuer | 16.20 | 135.60k | -0.33% |
| 2026-03-01 | Mr. Ian Michael EstepanPresident & COO | 3.95k | 0.00 | Derivative Exercise and Retained Stock | - | 204.70k | 1.97% |
| 2026-03-01 | Mr. Ian Michael EstepanPresident & COO | -4.18k | 67.65k | Derivative Exercise and Sale | 16.20 | 204.70k | - |
| 2026-03-01 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | 3.64k | 0.00 | Derivative Exercise and Retained Stock | - | 227.67k | 1.62% |
| 2026-03-01 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -4.49k | 72.66k | Derivative Exercise and Sale | 16.20 | 227.67k | - |
| 2026-02-26 | Mr. Ian Michael EstepanPresident & COO | 7.45k | 102.14k | Derivative Exercise and Retained Stock | 13.71 | 200.75k | 3.85% |
| 2026-01-29 | Dr. Claude NicaiseIndependent Non-Employee Director | -6.78k | 50.99k | Derivative Exercise and Sale | 13.71 - 21.23 | 29.15k | - |
| 2026-01-29 | Dr. Claude NicaiseIndependent Non-Employee Director | 3.72k | 51.00k | Derivative Exercise and Retained Stock | 13.71 | 29.15k | 14.63% |
| 2026-01-27 | Dr. M. Kathleen Behrens WilseyIndependent Chairwoman | 4.01k | 54.92k | Derivative Exercise and Retained Stock | 13.71 | 205.10k | 1.99% |
| 2026-01-27 | Dr. M. Kathleen Behrens WilseyIndependent Chairwoman | -6.49k | 54.94k | Derivative Exercise and Sale | 13.71 - 22.17 | 205.10k | - |
| 2025-12-16 | Mr. Ian Michael EstepanPresident & COO | -13.19k | 294.20k | 売り | 22.31 | 193.30k | -6.39% |
| 2025-12-01 | Mr. Ryan H. WongExec. VP & CFO | -158.00 | 3.31k | Sale to Issuer | 20.96 | 136.05k | -0.12% |
| 2025-11-28 | Cristin Rothfussインサイダー | -229.00 | 4.84k | Sale to Issuer | 21.12 | 139.76k | -0.16% |
| 2025-11-17 | Dr. Louise R. Rodino-KlapacPresident of Research & Development and Technical Operations | -4.58k | 84.40k | Sale to Issuer | 18.42 | 224.03k | -2.00% |
| 2025-07-31 | Mr. Ryan H. WongExec. VP & CFO | -327.00 | 5.37k | Sale to Issuer | 16.42 | 17.33k | -1.85% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
